Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Moustaki M, Paschou SA, Xekouki P, Kotsa K, Peppa M, Psaltopoulou T, Kalantaridou S, Vryonidou A (2023) Secondary diabetes mellitus in acromegaly. Endocrine. ;81(1):1–15. doi: 10.1007/s12020-023-03339-1. Epub 2023 Mar 8. PMID: 36882643; PMCID: PMC10239382
2. Esposito D, Boguszewski CL, Colao A, Fleseriu M, Gatto F, Jørgensen JOL, Ragnarsson O, Ferone D, Johannsson G Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management. Nat Rev Endocrinol. 2024 Jun 6. https://doi.org/10.1038/s41574-024-00993-x. Epub ahead of print. PMID: 38844688
3. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, Pavkov ME, Ramachandaran A, Wild SH, James S, Herman WH, Zhang P, Bommer C, Kuo S, Boyko EJ, Magliano DJ (2022) IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. ;183:109119. https://doi.org/10.1016/j.diabres.2021.109119. Epub 2021 Dec 6. Erratum in: Diabetes Res Clin Pract. 2023;204:110945. doi: 10.1016/j.diabres.2023.110945. PMID: 34879977; PMCID: PMC11057359
4. Li YL, Zhang S, Guo XP, Gao L, Lian W, Yao Y, Deng K, Wang RZ, Xing B Correlation analysis between short-term insulin-like growth factor-I and glucose intolerance status after transsphenoidal adenomectomy in acromegalic patients: a large retrospective study from a single center in China. Arch Endocrinol Metab 2019 Mar-Apr ;63(2):157–166. doi: 10.20945/2359-3997000000118. Epub 2019 Mar 21. PMID: 30916168; PMCID: PMC10522129.
5. Berkmann S, Brun J, Schuetz P, Christ E, Mariani L, Mueller B (2021) Prevalence and outcome of comorbidities associated with acromegaly. Acta Neurochir (Wien) 163(11):3171–3180. https://doi.org/10.1007/s00701-021-04846-8Epub 2021 Apr 15. PMID: 33856552